Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Azelastine in Moderate to Severe Allergic Rhinitis
NCT04561687Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of montelukast and azelastine in allergic rhinitis (AR), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Sino-Nasal Outcome Test at 3 months. Status: unknown.
02
Drugs
montelukastazelastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04561687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04561687.